Anxiety and depression in newly diagnosed epilepsy
Anxiety affects 35% of newly diagnosed epilepsy patients, highlighting the need for early screening and support.
Anxiety affects 35% of newly diagnosed epilepsy patients, highlighting the need for early screening and support.
Epilepsy is linked to a higher risk of diabetes and its complications, emphasizing the need for prevention and better management.
Podcast about exploring safe and effective use of antidepressants for people living with both epilepsy and depression.
The STEP survey is providing a number of insights into differing perspectives on seizure control and seizure freedom.
Insights from the Angelini Pharma Satellite Symposium at EAN 2024 on avoiding both overtreatment and undertreatment.
Podcast where Prof. Dr. Bernhard Steinhoff addresses how personalised care is transforming epilepsy management.
Machine learning is transforming epilepsy care, aiding in seizure focus detection, outcome prediction, and brain imaging analysis.
Insights from the Angelini Pharma Satellite Symposium at EAN 2024 on avoiding both overtreatment and undertreatment.